The observed difference in age of onset of this untoward complication could potentially be attributed to the type of mutation and its impact on the 11-cis retinol dehydrogenase activity; however, we included in our series patients with the same mutations whose disease was stationary without cone dystrophy. This evidence concerns the gene RDH5 and cone dystrophy.